department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE · pharmadog

pharmadog
drugs
NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE

drug · small molecule

patient view →

NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE

updated 2mo ago

by $AMRX Amneal Pharmaceuticals, Inc.🔗 ChEMBL

community read0 votes

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 35 approved and 37 investigational indications.

targets

Glucocorticoid receptor

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

brand

NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE

trade names

Acetasol hc, Acticort, Aeroseb-hc, Ala-cort, Ala-scalp, Alkindi

generic

HYDROCORTISONE

MOA

Glucocorticoid receptor agonist

indication

INDICATIONS AND USAGE For the treatment of superficial bacterial infections of the external auditory canal caused by organisms susceptible to the action of the antibiotics.

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 1h ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

🐶 often sniffed alongside

top 8

tagApproval18 co-mentions · 5 sources
drugHYDROCORTISONE16 co-mentions · 6 sources
drugET-80016 co-mentions · 6 sources
drugpolymyxin B6 co-mentions · 2 sources
drugCIPROFLOXACIN HYDROCHLORIDE2 co-mentions · 1 sources
drugciprofloxacin2 co-mentions · 1 sources
drugciprofloxacin hydrochloride ER2 co-mentions · 1 sources
tagSmall Molecule1 co-mentions · 1 sources

Trials studying NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE

phase3A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)recruitingn=1,314
phase1A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapyrecruitingn=36
phase3Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)recruitingn=1,310
phase1A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001)completedn=14
phase1Venetoclax Basket Trial for High Risk Hematologic Malignanciesrecruitingn=30
phase1Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)recruitingn=86
phase1A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005)active not recruitingn=6
phase2Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)recruitingn=100

more trials →